#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3583829	B	Inhibition of human CYP17 expressed in COS7 cells incubated for 1 hr before 17-hydroxypregnenolone substrate addition by EIA method	Homo sapiens	4	ALA3580617	cell-based format	Scientific Literature
2.	ALA3583830	B	Inhibition of CYP19 (unknown origin) using MFC substrate incubated for 30 mins	Homo sapiens	4	ALA3580617	single protein format	Scientific Literature
3.	ALA3583831	B	Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay	Homo sapiens	37	ALA3580617	cell-based format	Scientific Literature
4.	ALA3583832	B	Inhibition of human CYP11B1 expressed in V79 cells incubated for 1 hr before 11-deoxycortisol substrate addition by HTRF-based assay	Homo sapiens	37	ALA3580617	cell-based format	Scientific Literature
5.	ALA3583833	B	Selectivity index, ratio of IC50 for human CYP11B1 to IC50 for human CYP11B2	Homo sapiens	37	ALA3580617	assay format	Scientific Literature
6.	ALA3583834	A	Fraction unbound in rat plasma at 2.5 mM incubated for 4 hrs by equilibrium dialysis and LC/MS method	Rattus norvegicus	7	ALA3580617	cell-free format	Scientific Literature
7.	ALA3583835	A	Intrinsic clearance in rat liver microsomes at 0.3 mM incubated for 10 mins before NADPH addition by LC/MS method	Rattus norvegicus	7	ALA3580617	assay format	Scientific Literature
8.	ALA3583836	A	Oral bioavailability in Sprague-Dawley rat at 2 mg/kg by LC-MS/MS method	Rattus norvegicus	7	ALA3580617	organism-based format	Scientific Literature
9.	ALA3583943	A	Dose normalized AUC in Sprague-Dawley rat at 2 mg/kg, po or 1 mg/kg, iv by LC-MS/MS method	Rattus norvegicus	7	ALA3580617	organism-based format	Scientific Literature
10.	ALA3583944	A	Plasma clearance in Sprague-Dawley rat at 2 mg/kg, po or 1 mg/kg, iv by LC-MS/MS method	Rattus norvegicus	7	ALA3580617	organism-based format	Scientific Literature
11.	ALA3583945	B	Inhibition of human CYP21 expressed in COS7 cells incubated for 1 hr before 17-hydroxypregnenolone substrate addition by HTRF-based assay	Homo sapiens	4	ALA3580617	cell-based format	Scientific Literature
12.	ALA3583946	A	Inhibition of CYP3A4 (unknown origin)	Homo sapiens	4	ALA3580617	single protein format	Scientific Literature
13.	ALA3583947	A	Inhibition of CYP2C9 (unknown origin)	Homo sapiens	3	ALA3580617	single protein format	Scientific Literature
14.	ALA3583948	A	Inhibition of CYP2D6 (unknown origin)	Homo sapiens	3	ALA3580617	single protein format	Scientific Literature
15.	ALA3583949	B	Selectivity index, ratio of IC50 for CYP19 (unknown origin) to IC50 for human CYP11B2	Homo sapiens	4	ALA3580617	assay format	Scientific Literature
16.	ALA3583956	A	Fraction unbound in rhesus monkey plasma at 2.5 mM incubated for 4 hrs by equilibrium dialysis and LC/MS method	Macaca mulatta	3	ALA3580617	cell-free format	Scientific Literature
17.	ALA3583957	A	Intrinsic clearance in rhesus monkey liver microsomes at 0.3 mM incubated for 10 mins before NADPH addition by LC/MS method	Macaca mulatta	3	ALA3580617	assay format	Scientific Literature
18.	ALA3583958	A	Oral bioavailability in rhesus monkey at 1 mg/kg by LC-MS/MS method	Macaca mulatta	3	ALA3580617	organism-based format	Scientific Literature
19.	ALA3583959	A	Dose normalized AUC in rhesus monkey at 1 mg/kg, po or 0.5 mg/kg, iv by LC-MS/MS method	Macaca mulatta	3	ALA3580617	organism-based format	Scientific Literature
20.	ALA3583960	A	Plasma clearance in rhesus monkey at 1 mg/kg, po or 0.5 mg/kg, iv by LC-MS/MS method	Macaca mulatta	3	ALA3580617	organism-based format	Scientific Literature